Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Atwood Oceanics, Inc. (ATW): Are Hedge Funds Right About This Stock?

Page 1 of 2

Should Atwood Oceanics, Inc. (NYSE:ATW) investors track the following data?

In the financial world, there are many indicators investors can use to analyze stocks. Two of the most underrated are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the best fund managers can outclass the S&P 500 by a very impressive amount (see just how much).

Equally as useful, positive insider trading sentiment is a second way to analyze the world of equities. Just as you’d expect, there are plenty of motivations for an upper level exec to cut shares of his or her company, but only one, very obvious reason why they would buy. Several empirical studies have demonstrated the impressive potential of this tactic if “monkeys” know what to do (learn more here).

What’s more, it’s important to analyze the latest info about Atwood Oceanics, Inc. (NYSE:ATW).

Hedge fund activity in Atwood Oceanics, Inc. (NYSE:ATW)

At the end of the second quarter, a total of 19 of the hedge funds we track were long in this stock, a change of 36% from one quarter earlier. With hedge funds’ capital changing hands, there exists an “upper tier” of noteworthy hedge fund managers who were upping their holdings substantially.

Atwood Oceanics, Inc. (NYSE:ATW)Out of the hedge funds we follow, David Dreman’s Dreman Value Management had the largest position in Atwood Oceanics, Inc. (NYSE:ATW), worth close to $31.8 million, accounting for 1% of its total 13F portfolio. Coming in second is First Pacific Advisors LLC, managed by Robert Rodriguez and Steven Romick, which held a $29.7 million position; 0.3% of its 13F portfolio is allocated to the stock. Other hedgies that hold long positions include Greg Poole’s Echo Street Capital Management, Chuck Royce’s Royce & Associates and Israel Englander’s Millennium Management.

With a general bullishness amongst the titans, certain bigger names were leading the bulls’ herd. Dreman Value Management, managed by David Dreman, initiated the biggest position in Atwood Oceanics, Inc. (NYSE:ATW). Dreman Value Management had 31.8 million invested in the company at the end of the quarter. Robert Rodriguez and Steven Romick’s First Pacific Advisors LLC also initiated a $29.7 million position during the quarter. The other funds with new positions in the stock are Greg Poole’s Echo Street Capital Management, Chuck Royce’s Royce & Associates, and Israel Englander’s Millennium Management.

What have insiders been doing with Atwood Oceanics, Inc. (NYSE:ATW)?

Insider buying made by high-level executives is best served when the primary stock in question has seen transactions within the past 180 days. Over the last half-year time frame, Atwood Oceanics, Inc. (NYSE:ATW) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Atwood Oceanics, Inc. (NYSE:ATW). These stocks are Pengrowth Energy Corp (USA) (NYSE:PGH), Rowan Companies PLC (NYSE:RDC), Halcon Resources Corp (NYSE:HK), Enerplus Corp (USA) (NYSE:ERF), and Patterson-UTI Energy, Inc. (NASDAQ:PTEN). All of these stocks are in the oil & gas drilling & exploration industry and their market caps are similar to ATW’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!